Each start-up to receive up to Rs.25 lakhs as funding support
To encourage and support startups in India and help early-stage innovators advance on their journey, Pfizer https://www.pfizer.com/ is supporting healthcare start-ups in turning their innovative ideas into market-ready solutions through collaboration with the National Institute of Pharmaceutical Education & Research (NIPER) http://www.niperhyd.ac.in/ , Ahmedabad.
The initiative is being supported by the Department of Pharmaceuticals and NITI Aayog https://www.niti.gov.in/ and is being anchored by Social Alpha.
Pfizer https://www.who.int/ Managing Director Meenakshi Nevatia said on 26 Feb, “Through the Pfizer INDovation platform, we are proud to have given wing to startups that are addressing important unmet needs in areas of Oncology, Digital Health https://main.mohfw.gov.in/ , Devices and Diagnostics.
“We look forward to welcoming our latest cohort of startups to this program and being a part of their journey to success.”
This partnership expands on the successful Pfizer INDovation initiative, through which 34 startups in India have already been supported through funding and incubation to bring their breakthroughs to market.
Through this partnership with NIPER Ahmedabad https://niperahm.ac.in/, this initiative will follow a cohort-based approach with the aim of selecting 6 innovators pan-India, that will be incubated at NIPER Ahmedabad.
Start-ups https://www.startupindia.gov.in/ with a proof-of-concept that matches the set mandate will be selected for a one-year accelerator program.
Each of these startups will receive incubation support in areas of product development, regulatory pathway, pre-clinical testing, tech transfer support through NIPER ecosystem and real-world clinical fitment check. They will also receive funding support of up to Rs.25 lakhs each.
Pfizer, in India since 1950, has one of the most comprehensive presences in the country through large scale manufacturing and state-of-the-art R&D operations. Fiinews.com
